Page 1305 - Equine Clinical Medicine, Surgery and Reproduction, 2nd Edition
P. 1305

1280                                       CHAPTER 12



  VetBooks.ir  Differential diagnosis                     the animal’s life, although in rare cases, especially in
                                                          younger horses, medications can be slowly tapered
           Dermatophilosis; dermatophytosis; onchocercia-
           sis;  Culicoides  dermatitis; equine granulomatous
                                                            Attempts to address underlying trigger factors
           enteritis;  equine  viral papular  dermatitis;  equine   and discontinued.
             sarcoidosis; epitheliogenesis imperfecta; junctional   may ultimately allow tapering and discontinua-
             mechanobullous disease; coronary band dystrophy;   tion  of  immunosuppressive  therapy.  In  every  case
           seborrhoea; generalised skin eruptions of unknown   of immune-mediated dermatitis, it is worth ruling
           aetiology; Malassezia spp. (yeast) dermatitis.  out: underlying causes such as food allergy, by per-
                                                          forming dietary elimination trials; environmental
           Diagnosis                                      allergies,  by  pursuing  intradermal  allergy  testing
           History and clinical appearance are   suggestive.   and immunotherapy; insect bite hypersensitivity, by
           Diff-Quik-stained stained direct impression    instituting insect repellent measures and also con-
           smears can be taken from crusts and intact vesicles   sidering  ASIT.  It  is  also  worth  discontinuing and
           or pustules, revealing acantholytic cells among a sea   avoiding offending medications or supplements if
           of neutrophils. Multiple biopsies should be taken   the history is suggestive of a drug reaction.
           from multiple sites, which must always include a
           well-adhered surface; that is, the skin should not  Prognosis
           be cleansed or shaved prior to biopsy in order to   The long-term prognosis is guarded. Foals (<1 year
           avoid disrupting the surface crust. Histopathology   of age) may have milder clinical signs and respond
           should be performed by a pathologist with a strong   more favourably to treatment than older horses.
           interest in equine dermatology because the lesions
           at times can be subtle. Attaching digital clinical  EQUINE PEMPHIGUS VULGARIS
           photos to the histopathology submission may help  AND BULLOUS PEMPHIGOID
           prompt the   pathologist to request further serial
           sections should the initial cut fail to provide rep-  Definition/overview
           resentative acantholytic findings. Direct immu-  These vesicobullous ulcerative diseases are extremely
           nofluorescence testing or immunohistochemistry   rare conditions in the horse. They affect the oral
           shows intracellular deposits of immunoglobulin   cavity (Fig. 12.84), mucocutaneous junction or skin,
           in the epidermis. As acantholysis may also be the   or a combination of all three.
           result of exfoliative toxins released by bacteria and
           dermatophytes, in particular  Trichophyton spp.,
           requests for special stains should always accom-
           pany each histopathological submission where   12.84
           pemphigus is suspected.

           Management
           Immunosuppressive doses of corticosteroids are
           indicated (prednisolone, 2–4 mg/kg q12 h for 7–14
           days). Attempts should then be made to change to
           alternate-day therapy. Azathioprine (3–5  mg/kg
           q24 h) can also be used, as a corticosteroid- sparing
           medication. Note that horses have high levels of
           thiopurine methyl transferase activity, hence the
           need  for  unusually  high  doses  of  azathioprine.
           Pentoxifylline (8–10 mg/kg q12 h) may also pro-
           vide anti- inflammatory and steroid-sparing effects.   Fig. 12.84  Bullous pemphigoid erosion in the
           Treatment may need to be continued for the rest of   mouth. (Photo courtesy DW Scott)
   1300   1301   1302   1303   1304   1305   1306   1307   1308   1309   1310